Form 8-K - Current report:
SEC Accession No. 0000929638-25-003494
Filing Date
2025-09-16
Accepted
2025-09-16 16:35:38
Documents
14
Period of Report
2025-09-16
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 a8k.htm   iXBRL 8-K 25516
2 exhbit99-1.htm EX-99 20111
6 image00001.jpg GRAPHIC 11719
  Complete submission text file 0000929638-25-003494.txt   188035

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ctso-20250916.xsd EX-101.SCH 3877
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctso-20250916_lab.xml EX-101.LAB 21966
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctso-20250916_pre.xml EX-101.PRE 16052
16 EXTRACTED XBRL INSTANCE DOCUMENT a8k_htm.xml XML 4063
Mailing Address 305 COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 305 COLLEGE ROAD EAST PRINCETON NJ 08540 973-329-8885
Cytosorbents Corp (Filer) CIK: 0001175151 (see all company filings)

EIN.: 980373793 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36792 | Film No.: 251317737
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)